Product Discontinuation Analysis Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035
Product discontinuation analysis in the biopharma and advanced therapy sectors investigates the underlying clinical, commercial, financial, and strategic drivers behind drug candidate withdrawals, clinical trial terminations, and commercial product sun-setting. Analyzing why pipeline candidates fail—whether due to unexpected off-target toxicity, unviable cost-of-goods (COGS), or shifting...